Sobi's 2025 annual revenue and adjusted EBITA margin exceed previous outlook [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
Full-year revenue was approximately SEK 28.2 B, representing approximately 15 per cent growth at constant exchange rate (CER)[1]. Adjusted EBITA margin1,[2] was approximately 40 per cent of revenues. The main reason for the increased revenue was higher than expected Q4 sales for Doptelet, Gamifant and the Haemophilia portfolio. The adjusted EBITA margin¹ ² was increased due to the higher than expected revenue. At the publication of the Q3 2025 report on 20 October 2025 Sobi stated the outlook for the full year 2025 to be: Revenue was anticipated to grow by a low double-digit percentage at CER¹ and adjusted EBITA margin¹ ² was anticipated to be in the mid to high-30s per cent of revenue. Sobi will announce its fourth quarter and full year 2025 report on Thursday 5 February 2026 at 8:00 am CET. Sobi® Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Nasdaq (NASDAQ:NDAQ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Nasdaq (NASDAQ:NDAQ) had its price target raised by analysts at TD Cowen from $96.00 to $104.00. They now have a "hold" rating on the stock.MarketBeat
- Nasdaq (NASDAQ:NDAQ) had its "hold" rating reaffirmed by analysts at Cowen Inc.MarketBeat
- Invitation: Sobi's Q4 and FY 2025 report [Yahoo! Finance]Yahoo! Finance
- Delisting of Securities from The Nasdaq Stock MarketGlobeNewswire
NDAQ
Earnings
- 10/21/25 - Beat
NDAQ
Sec Filings
- 1/16/26 - Form 8-K
- 1/8/26 - Form 4
- 1/6/26 - Form 144
- NDAQ's page on the SEC website